KIMIA BIOSCIENCES
Quarterly Results Analysis [Dec2024]
KIMIA BIOSCIENCES Quarterly Results
Standalone | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹30 Cr | ₹28 Cr | ₹22 Cr | ₹30 Cr | ₹26 Cr | ₹24 Cr | ₹24 Cr | ₹23 Cr |
Expenses | ₹25 Cr | ₹25 Cr | ₹19 Cr | ₹26 Cr | ₹27 Cr | ₹26 Cr | ₹26 Cr | ₹28 Cr |
Operating Income | ₹5 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹-1 Cr | ₹-2 Cr | ₹-2 Cr | ₹-5 Cr |
Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹-3 Cr | ₹-3 Cr | ₹-4 Cr | ₹-8 Cr |
Profit After Tax | ₹5 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹-2 Cr | ₹-2 Cr | ₹-3 Cr | ₹-6 Cr |
EPS | ₹0.97 | ₹0.34 | ₹0.30 | ₹0.38 | ₹-0.41 | ₹-0.52 | ₹-0.57 | ₹-1.30 |
Industry Peers & Returns | 1W | 1M | 1Y |
KIMIA BIOSCIENCES | -2.8% | -6% | -19% |
SUN PHARMACEUTICAL INDUSTRIES | -1.5% | 9.1% | 9.1% |
DIVIS LABORATORIES | -4.9% | -0.6% | 59.1% |
CIPLA | -1.8% | 1% | 0.5% |
TORRENT PHARMACEUTICALS | 1.6% | 12.1% | 21.8% |
DR REDDYS LABORATORIES | -3% | -0.9% | -7.7% |
MANKIND PHARMA | 1.1% | 7.6% | 1.3% |
ZYDUS LIFESCIENCES | -2.2% | -0.6% | -9.3% |
LUPIN | -2.7% | 1% | 30.1% |
KIMIA BIOSCIENCES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 6.81 % |
Y-o-Y | 15.12 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹30 Cr | 6.81 | |
Sep2024 | ₹28 Cr | 25.80 | |
Jun2024 | ₹22 Cr | -26.08 | |
Mar2024 | ₹30 Cr | 15.90 | |
Dec2023 | ₹26 Cr | 8.04 | |
Sep2023 | ₹24 Cr | -0.12 | |
Jun2023 | ₹24 Cr | 6.91 | |
Mar2023 | ₹23 Cr | - |
KIMIA BIOSCIENCES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 48.25 % |
Y-o-Y | Positive |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹5 Cr | 48.25 | |
Sep2024 | ₹3 Cr | -9.04 | |
Jun2024 | ₹4 Cr | -11.07 | |
Mar2024 | ₹4 Cr | Positive | |
Dec2023 | ₹-1 Cr | Negative | |
Sep2023 | ₹-2 Cr | Negative | |
Jun2023 | ₹-2 Cr | Negative | |
Mar2023 | ₹-5 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 38.80 % |
Y-o-Y | Positive |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 16.6% | 38.80 | |
Sep2024 | 11.96% | -27.69 | |
Jun2024 | 16.54% | 20.29 | |
Mar2024 | 13.75% | Positive | |
Dec2023 | -4% | Negative | |
Sep2023 | -8.11% | Negative | |
Jun2023 | -6.76% | Negative | |
Mar2023 | -23.67% | - |
KIMIA BIOSCIENCES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 182.97 % |
Y-o-Y | Positive |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹5 Cr | 182.97 | |
Sep2024 | ₹2 Cr | 12.31 | |
Jun2024 | ₹1 Cr | -19.98 | |
Mar2024 | ₹2 Cr | Positive | |
Dec2023 | ₹-2 Cr | Negative | |
Sep2023 | ₹-2 Cr | Negative | |
Jun2023 | ₹-3 Cr | Negative | |
Mar2023 | ₹-6 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 164.92 % |
Y-o-Y | Positive |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 15.18 % | 164.92 | |
Sep2024 | 5.73 % | -10.75 | |
Jun2024 | 6.42 % | 8.26 | |
Mar2024 | 5.93 % | Positive | |
Dec2023 | -7.47 % | Negative | |
Sep2023 | -10.09 % | Negative | |
Jun2023 | -11.19 % | Negative | |
Mar2023 | -27.2 % | - |
KIMIA BIOSCIENCES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 185.29 % |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹0.97 | 185.29 | |
Sep2024 | ₹0.34 | 13.33 | |
Jun2024 | ₹0.3 | -21.05 | |
Mar2024 | ₹0.38 | Positive | |
Dec2023 | ₹-0.41 | Negative | |
Sep2023 | ₹-0.52 | Negative | |
Jun2023 | ₹-0.57 | Negative | |
Mar2023 | ₹-1.3 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD